40545-65-1

Usage

Uses

Used in Pharmaceutical Industry:
4-(4-Chloro-phenyl)-2H-pyrazol-3-ylamine is used as a lead molecule for drug development for its potential therapeutic applications in treating various diseases such as cancer, inflammation, and neurological disorders. Its ability to interact with biological targets makes it a valuable compound in the search for new treatments.
Used in Cancer Treatment:
In the field of oncology, 4-(4-Chloro-phenyl)-2H-pyrazol-3-ylamine is used as a potential anticancer agent. Its pharmacological effects are being investigated for its ability to target and treat different types of cancer by interacting with specific biological targets involved in cancer progression.
Used in Inflammation Management:
4-(4-Chloro-phenyl)-2H-pyrazol-3-ylamine is also being studied for its potential use in managing inflammation. Its interaction with biological targets involved in inflammatory processes could lead to the development of new anti-inflammatory drugs.
Used in Neurological Disorders Treatment:
In the realm of neurology, 4-(4-Chloro-phenyl)-2H-pyrazol-3-ylamine is being explored for its potential to treat neurological disorders. Its pharmacological properties may offer new avenues for the development of treatments for conditions such as Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.
Further research is ongoing to fully understand the pharmacological effects and potential applications of 4-(4-Chloro-phenyl)-2H-pyrazol-3-ylamine, with the aim of harnessing its therapeutic potential for the benefit of patients suffering from various diseases.

InChI:InChI=1/C9H8ClN3/c10-7-3-1-6(2-4-7)8-5-12-13-9(8)11/h1-5H,(H3,11,12,13)

Upstream product

• 62538-21-0 2-(4-chloro-phenyl)-3-oxo-propionitrile 
• 13014-48-7 4-chlorobenzoyl cyanide 

Downstream Products

• 1264295-43-3 ethyl 2-(7-(4-chlorophenyl)pyrazolo[5,1-b]thiazol-3-yl)-2-methyl-3-phenylpropanoate 
• 1264296-63-0 ethyl 2-(3-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidin-7-yl)propanoate 
• 1264296-97-0 (S)-ethyl 2-(3-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidin-7-yl)-2-methyl-3-phenylpropanoate 
• 1264295-86-4 (R)-ethyl 2-(3-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidin-7-yl)-2-methyl-3-phenylpropanoate 
• 1264295-79-5 C₂₅H₂₄ClN₃O₃ 
• 1264295-56-8 C₂₁H₁₉ClN₄O₂S 
• 1264295-61-5 ethyl 2-(3-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidin-7-yl)-2-methyl-3-(pyridin-3-yl)propanoate 
• 1264295-54-6 C₂₃H₂₆ClN₃O₃ 
• 1264295-52-4 C₂₁H₂₄ClN₃O₂ 
• 1264295-51-3 C₂₅H₂₄ClN₃O₂ 
• 1264295-50-2 C₂₅H₂₄ClN₃O₂ 
• 1264295-49-9 ethyl 2-(3-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidin-7-yl)-2-methyl-3-p-tolylpropanoate 
• 1264294-79-2 ethyl 2-benzyl-2-(3-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidin-7-yl)pentanoate 
• 1609173-40-1 C₂₀H₁₄Cl₂FN₃ 

Relevant academic research and scientific papers

Structure and tautomerism of 4-substituted 3(5)-aminopyrazoles in solution and in the solid state: NMR study and Ab initio calculations

Annular tautomerism of 3(5)-aminopyrazoles containing a cyano, thiocyanato, or aryl substituent in the 4-position has been studied by 1H and 13C NMR in solution, cross-polarization and magic-angle spinning 13C NMR in the s

Study of regioselectivity of reactions between 3(5)-aminopyrazoles and 2-acetylcycloalkanones

Regioselectivity was examined of reactions between nine 3(5)-aminopyrazoles and 2-acetylcyclopentanone and 2-acetylcyclohexanone under various conditions. A series of cyclopenta[e]pyrazolo-[1,5-a]pyrimidines was obtained. The highest regioselectivity of the reaction was observed in alcohol at 20°C in the presence of a catalytic quantity of trifl uoroacetic acid. The regiostructure of compounds was established by 1H and 13C NMR spectroscopy. Pleiades Publishing, Ltd., 2012.